COVID-19 vaccination in patients with classic and variant hairy cell leukemia
Robert J. Kreitman(National Cancer Institute), Evgeny Arons(National Institutes of Health), Constance M. Yuan(National Cancer Institute), Jeffrey I. Cohen(National Institutes of Health), Holly Eager(National Institutes of Health), Peter D. Burbelo(National Institutes of Health), Julie Feurtado(National Institutes of Health), Hao‐Wei Wang(Fu Jen Catholic University), Hong Zhou(Jinyintan Hospital), M N Gould(National Institutes of Health), Olena Sierra Ortiz(National Institutes of Health), Isaac Shpilman(National Institutes of Health), Lacey James(National Institutes of Health)
Cited by 0
Related Papers
The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee
|Blood|2022|1.5k
IL-4 induces cathepsin protease activity in tumor-associated macrophages to promote cancer growth and invasion
|Genes & Development|2010|744
CREB as a Memory Modulator: induced expression of a dCREB2 activator isoform enhances long-term memory in drosophila
|Cell|1995|649
CD4/CD8 T-Cell Selection Affects Chimeric Antigen Receptor (CAR) T-Cell Potency and Toxicity: Updated Results From a Phase I Anti-CD22 CAR T-Cell Trial
|Journal of Clinical Oncology|2020|422
Plasma Proteomics Identify Biomarkers and Pathogenesis of COVID-19
|Immunity|2020|387